Current Cause and Management of Irritable Bowel Syndrome in Basrah, Iraq

Abstract Background: Irritable bowel syndrome (IBS) is a common functional disorder of the gastrointestinal tract in which the patient experiences abdominal pain and altered bowel habits. Objective: The present study was designed to investigate the common causes, associated factors, and treatment of IBS in Basra City. Materials and Methods: A cross-sectional study was conducted in Basra city, involving 253 patients with IBS who completed a web-based pre-tested, structured questionnaire, during the period from January to July 2021. Questions about demographic characteristics, personal history, and types of bowel habits were included. Results: The common symptoms reported were flatulence, gastric upset, constipation, and abdominal pain, with prevalences 209, 133, 116, and 111, respectively. Most patients were not smokers, consuming caffeinated drinks, cola, chocolates, and a mixed diet. In addition, their sleeping hours were insufficient, and they had no sports activities. Approximately, 108 patients had a family history of IBS. The majority of patients in this study used drugs such as mebeverine, antacids, and charcoal to alleviate their symptoms. Conclusion: The most notable symptoms reported by patients in this study were flatulence, gastric upset, constipation, and abdominal pain. The risk factors for IBS in this study included male gender, family history of IBS, consumption of caffeinated drinks, and drugs like nonsteroidal anti-inflammatory drugs. Mebeverine, antacids, and charcoal were the most commonly used drugs for treating IBS in Basra city.